Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized 13C Pyruvate MRI in Pancreatic Cancer
NCT04565327Phase 2Terminated
- Start
- Aug 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [1-13C]pyruvate in pancreatic ductal adenocarcinoma (PDAC). Started Aug 2020; status: terminated.
02
Drugs
[1-13C]pyruvate
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04565327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04565327.